| KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION Patent applications |
| Patent application number | Title | Published |
|---|
| 20120024077 | INCLUSION RATING METHOD - An inclusion rating method includes carrying out a tensile test on a test specimen, which is made of a metallic material and charged with a hydrogen, to cause a fracture originating from a nonmetallic inclusion affected by the hydrogen in the test specimen, identifying a type of the nonmetallic inclusion, measuring a size of the nonmetallic inclusion, and evaluating a cleanliness of the metallic material by obtaining a distribution function of the size of the nonmetallic inclusion. | 02-02-2012 |
| 20110295383 | BONE SUBSTITUTE MATERIAL FOR MEDICAL USE AND METHOD OF PRODUCING THE SAME - There is disclosed a bone substitute material for medical use which satisfies all the requirements of (1) no histotoxicity, (2) osteoconductivity, (3) bone replacement capability, and (4) mechanical strength necessary for a bone reconstruction operation. The bone substitute material for medical use is predominantly composed of carbonate apatite and produced through the formation of carbonate apatite by contacting a block of calcium compound with a phosphate-containing solution, wherein the calcium compound block contains substantially no powders, and at least one of said calcium compound block and said phosphate solution contains a carbonate group, without any sintering. The block of calcium compound is preferably one prepared using an artificially synthesized calcium compound, most preferably a foamed calcium compound. | 12-01-2011 |
| 20110263861 | QUINOLINE COMPOUND - Provided is a solid luminescent quinoline compound capable of emitting light in a crystalline state, capable of changing the luminescent color not requiring modification of molecular configuration and capable of emitting light in response to external pressure such as heat, physical pressure, etc. The quinoline compound is represented by the following general formula (1): | 10-27-2011 |
| 20110217707 | EVALUATION/SCREENING METHOD FOR DISEASES ASSOCIATED WITH D-AMINO ACID UTILIZING DA01-/-MOUSE - Disclosed is an evaluation method which can rapidly discriminate a Dao | 09-08-2011 |
| 20110202107 | BLOOD PRESSURE STABILIZATION SYSTEM USING TRANSDERMAL STIMULATION - The present invention relates to an electric stimulation apparatus for treating hypotension of patients with spinal cord injury and a method for treating hypotension. An electric stimulation apparatus of the present invention comprises: a blood pressure measuring means for continuously measuring a blood pressure of a subject; an electric current application means for intermittently applying an electric current to skin of the subject; and a control means for controlling the electric current application means so as to maintain the blood pressure at a predetermined target blood pressure value by activating the electric current application means when the subject blood pressure is equal to or less than the target blood pressure value. | 08-18-2011 |
| 20110193734 | SIGNAL CONVERTER, PARAMETER DECIDING DEVICE, PARAMETER DECIDING METHOD, PROGRAM, AND RECORDING MEDIUM - A signal converter and the like, which can more accurately and stably realize signal conversion between an analog signal and a digital signal are proposed. In a β-encoder, when a logic value generated by at least a quantizer | 08-11-2011 |
| 20110189671 | NUCLEOSIDE TRIPHOSPHATE DERIVATIVE, NUCLEIC ACID PROBE, MULTILABELED NUCLEIC ACID PROBE, METHOD FOR PRODUCTION OF MULTILABELED NUCLEIC ACID PROBE, AND METHOD FOR DETECTION OF TARGET NUCLEIC ACID - A novel nucleoside triphosphate derivative, a nucleic acid probe, and a multilabeled nucleic acid probe that can detect a target nucleic acid conveniently and with high sensitivity, as well as a method for producing the multilabeled nucleic acid probe, and a method for detecting a target nucleic acid using the multilabeled nucleic acid probe or the nucleic acid probe. A target nucleic acid can be detected conveniently and with high sensitivity by using a transglutaminase (TGase), and by using a multilabeled nucleic acid probe in which a plurality of labeling portions have been introduced in advance by covalent binding, or by introducing a plurality of labeling portions by covalent binding into a nucleic acid probe that has been hybridized with the target nucleic acid. | 08-04-2011 |
| 20110184147 | ENZYME SUBSTRATE FOR LABELING OF PROTEIN - The present invention provides a substrate of TGase represented by (fluorescent group)-(linker)-(a portion containing a Gln residue capable of recognition by transglutaminase (TGase))-R, wherein the fluorescent group is fluorescein isothiocyanate (FITC), Texas Red (TE) or dansyl (Dns) or a group derived therefrom; the linker is a group represented by —NH—(CH | 07-28-2011 |
| 20110183058 | Pasteurizing Method and Pasteurizing Apparatus - In order to provide a pasteurizing method that provides high pasteurizing effect in pasteurization of an object to be treated and that hardly causes denaturation of the treated object, the method includes a dropping step of dropping the object in a steam zone and a contacting step of causing the dropping object to come into contact with the steam. | 07-28-2011 |
| 20110124916 | THERMAL RESPONSIVE MOLECULE - Provided is a thermal responsive molecule favorable as a thermal responsive low-molecular hydrogelling agent or the like that gels in response to heat. The thermal responsive molecule is characterized in that an amphiphilic side chain obtained by bonding a hydrophilic side chain such as triethylene glycol and a hydrophobic group such as an octyl group is introduced into a C | 05-26-2011 |
| 20110117588 | METHOD OF PREDICTING DRUG-INDUCED PHOSPHOLIPIDOSIS - The present invention provides a method of predicting drug-induced phospholipidosis, comprising a step of contacting a mammalian cell with a test compound, a step of measuring extracellular and/or intracellular lysosomal enzyme level or activity, or measuring intracellular LC3 level, and a step of selecting a test compound that has enhanced extracellular secretion of the enzyme or increased the protein level as a compound capable of inducing drug-induced phospholipidosis. | 05-19-2011 |
| 20110111051 | PROPHYLACTIC OR ALLEVIATING AGENT FOR PERIPHERAL NERVE DISORDER INDUCED BY ANTI-CANCER AGENT - There is provided a medicinal agent that is effective and highly safe for the prevention or alleviation of a peripheral nerve disorder that develops as a side effect occurring after the administration of an anti-cancer agent. The present invention relates to a novel medical use of an extract from inflamed tissues inoculated with vaccinia virus, and to a prophylactic or alleviating agent for a peripheral nerve disorder that contains the extract as an active ingredient. The agent containing the extract as an active ingredient is used for a prophylactic or alleviating agent for a peripheral nerve disorder induced by an anti-cancer agent and is a highly safe and remarkably highly useful medicinal agent with few side effects. | 05-12-2011 |
| 20110110233 | NETWORK SYSTEM, NODE, PACKET FORWARDING METHOD, PROGRAM, AND RECORDING MEDIUM - There is proposed a network system and the like achieving a packet relay transmission with high relay transmission efficiency according to Intermittent Periodic Transmit method (IPT). In order to achieve Intermittent Periodic Transmit in a mesh cluster, a communication control unit of a core node selects one of a plurality of communication units according to downlink priority and causes the selected communication unit to transmit a packet with a periodic interval. In order to transmit a packet from the core node to another slave node, a communication control unit of a slave node selects one of the communication units according to downlink priority, and in order to transmit a packet from a slave node to the core node, the communication control unit of the slave node selects one of the communication units according to uplink priority. Then, the communication control unit causes the selected communication unit to transmit the packet. | 05-12-2011 |
| 20110090835 | NETWORK SYSTEM, NODE,PACKET FORWARDING METHOD, PROGRAM, AND RECORDING MEDIUM - There are proposed: a network system capable of realizing packet forwarding higher in packet forwarding efficiency than in conventional Intermittent Periodic Transmit (IPT) using omni-directional antennas; and the like. Directional antennas are applied to the IPT, and each of slave nodes waits for reception of downlink packets by a directional antenna for receiving the downlink packets in a reception waiting state therefor. Moreover, the downlink packets are treated like polling control signals, and uplink packets are transmitted at a reception time of the downlink packets, whereby a hidden node problem and a carrier sensing problem can be avoided. Furthermore, in accordance with routing protocol in which each of nodes changes directivity randomly by a route formation process, it becomes possible to form a more suitable route. | 04-21-2011 |
| 20110042952 | FLUID MACHINE, WIND TURBINE, AND METHOD FOR INCREASING VELOCITY OF INTERNAL FLOW OF FLUID MACHINE, UTILIZING UNSTEADY FLOW - A fluid machine includes a non-streamline casing capable of forming a stable vortex street on a downstream side by internal and external flows, and an impeller disposed inside the casing. The casing has a vortex generator configured to form the vortex street on the downstream side. The vortex generator is provided with a phase control structure which regulates a phase of a vortex formation that fluctuates along a circumferential direction in a plane including a rear face of the casing and which clarifies a cell structure to be formed along the circumferential direction of the casing to fix, on a surface of the casing, respective positions of cells into a plurality of segmented regions arranged in the circumferential direction. The velocity of the internal flow is increased by the phase control structure. | 02-24-2011 |
| 20110015486 | ENDOSCOPE SYSTEM AND ENDOSCOPIC OPERATION TRAINING SYSTEM - An endoscope system or an endoscopic operation training system includes: projectors which project video light indicating a video taken by an endoscope device that allows at least a part thereof to be inserted into patient's body cavity; and a dome type screen having a shape of a projection surface that directs a concave surface toward an operator and assistants, in which the video light is projected onto the projection surface. In a case where an axis that passes through a center of an opening surface thereof and is perpendicular to the opening surface is defined as a first axis, a point where the first axis and the projection surface intersect each other is defined as a projection surface center, and an axis that connects the projection surface center and an edge portion of the projection surface to each other is defined as a second axis, and a tangential line of the edge portion of the projection surface is defined as a third axis, then an angle made by the first axis and the third axis is an angle at which it is possible to observe a whole of the video from the first viewpoint position, and an angle made by the first axis and the second axis is an axis at which it is possible to observe the projection surface center from the second viewpoint position. | 01-20-2011 |
| 20110003321 | Monitoring of Intercellular Mitochondorial Polarization - An object is a method of detecting changes in mitochondrial polarized state in a living cell. | 01-06-2011 |
| 20100331373 | DRUG-CONTAINING NANOPARTICLES - The present invention relates to nanoparticles containing pioglitazone or a salt thereof and a biocompatible polymer, a pharmaceutical preparation containing the nanoparticles for the prophylaxis or treatment of arteriosclerotic diseases, and a stent carrying the nanoparticles. Using the nanoparticles of the present invention, rupture of arteriosclerotic plaque can be suppressed, and they are useful for the prophylaxis or treatment of arteriosclerotic diseases. | 12-30-2010 |
| 20100321138 | SEPARATE TYPE MAGNETIC SHIELD APPARATUS - It is an object of the present invention to provide a separate type magnetic shield apparatus which has high access performance to a magnetically shielded space, in which magnetic shielding is very effectively achieved. In the separate type magnetic shield apparatus, first and second conductors | 12-23-2010 |
| 20100308313 | Organic Material Containing Oligophenylene Skeleton and Light-Emitting Device Using the Same - [Object] To provide a wide band-gap material capable of forming a stable amorphous thin film and an organic electroluminescent device using such a compound and having a high light emission efficiency. | 12-09-2010 |
| 20100300987 | FILTRATION APPARATUS AND FILTRATION METHOD - The present invention has an object to provide a filtration apparatus and a filtration method which can treat a large quantity of flow in a short time and can sterilize raw water to a high level using only a physical treatment. The filtration apparatus and the filtration method according to the present invention includes a spring filter | 12-02-2010 |
| 20100216977 | THERAPEUTIC AGENT FOR INTERSTITIAL PULMONARY DISEASE COMPRISING ANTI-HMGB-1 ANTIBODY - An objective of the present invention is to provide effective methods for treating interstitial pulmonary diseases including interstitial pneumonia such as IPF. The present invention suggests that antibodies against HMGB-1 are effective for treating pulmonary fibrosis. Thus, the present invention provides preparations which comprise an anti-HMGB-1 antibody for treating interstitial pulmonary diseases. | 08-26-2010 |
| 20100207796 | CONVERTER, CONVERSION METHOD, PROGRAM, AND RECORDING MEDIUM - Provided is a highly accurate converter and the like that makes up for the instability of circuit elements, by focusing on a relationship between the Markov chain and β conversion. A converter | 08-19-2010 |
| 20100112446 | ACTIVE ELECTRODE MATERIAL, MANUFACTURING METHOD OF SAME, AND LITHIUM-ION BATTERY USING THAT ACTIVE ELECTRODE MATERIAL - Electrode active material is provided which is mainly an amorphous iron-phosphate complex represented by Li | 05-06-2010 |
| 20100086615 | AGENT FOR TREATMENT OF PULMONARY DISEASE - To provide a pulmonary disease therapeutic drug exhibiting high efficacy and reduced side effects. | 04-08-2010 |
| 20100067365 | TRANSMISSION SYSTEM, TRANSMISSION METHOD, TRANSMITTER, RECEIVER, DECODING METHOD, AND DECODER - A transmission system capable of obtaining an effect of orthogonality among time block codes and an effect of path diversity on a distorted channel is provided. In the transmission system including: a transmitter device transmitting an information signal S[n] multiplied by a code, the code being a time block code constituted by a plurality of time series symbols, the transmitter device multiplying the information signal by a plurality of the time block codes, respectively, multiplexing multiplication results on a time axis and transmitting multiplexed signals; and a receiver device including a reception filter, if an impulse response matrix of a channel is a matrix H, a characteristic of the reception filter is set to be represented by a complex conjugate transpose matrix H | 03-18-2010 |
| 20100063048 | Remedy for angiospasm accompanying subarachnoid hemorrhage containing thrombin receptor antagonist as the active ingredient - A therapeutic agent for subarachnoid hemorrhage or a drug for improving prognosis of subarachnoid hemorrhage, comprising a compound having a PAR1 inhibitory effect, its pharmaceutically acceptable salt or a hydrate thereof | 03-11-2010 |
| 20100040323 | SUPER-LUMINESCENT LIGHT EMITTING DIODE - To provide a super luminescent light emitting diode comprising an optical waveguide structure which supplies particularly-high optical output. The super-luminescent light emitting diode includes: a first optical waveguide, of which one end is optically connected to one end of a multimode interference optical waveguide, and of which the other end forms a first light emitting edge; and a second optical waveguide, of which one end is optically connected to the other end of the multimode interference optical waveguide, and of which the other end forms a second light emitting edge. Each of the first and second optical waveguides has a width smaller than the width of the multimode interference optical waveguide. | 02-18-2010 |
| 20100035155 | CATHODE ACTIVE MATERIAL FOR NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY AND MANUFACTURING METHOD OF THE SAME - In a non-aqueous electrolyte secondary battery, in order to adjust a cathode active material in which guest cation such as Na and Li is included, alkaline metal fluoride which is expressed by a general formula AF and transition metal fluoride which is expressed by a formula M′ F | 02-11-2010 |
| 20090323010 | Liquid Crystal Composition and Liquid Crystal Element - The invention provides a liquid crystal composition having an optically isotropic liquid crystal phase used in an element driven in a state of an optically isotropic liquid crystal phase, which comprises a compound I having the clearing point T | 12-31-2009 |
| 20090305385 | Novel Cultured Silkworm Cells Capable of Highly Efficient Baculovirus Production and Protein Production - Known cell lines derived from silkworm exhibit low propagation efficiency of BmNPV. Accordingly, systems using known culture cell lines derived from silkworms take a long time to establish recombinant viruses, and are not suitable for preparation of virus solutions with high titers. The present invention provides a cell line Bme21 (FERM P-20852) that is derived from a silkworm embryo and is highly susceptible to BmNPV or its variant having the same biological characteristics. The present invention also provides a method of producing a recombinant virus, a method of producing a recombinant protein, a method of increasing efficiency of recombinant virus production, and a method of increasing efficiency of recombinant protein production, using the cell line Bme21 or its variant. | 12-10-2009 |
| 20090296638 | Wireless Communication Apparatus, Wireless Communication Method and Wireless Communication Program - In accordance with the present application, it is possible to determine whether or not it is appropriate to apply SDMA by estimating the fading speed of mobile stations. A wireless communication apparatus of the present application includes: a fading speed estimation portion ( | 12-03-2009 |
| 20090250333 | Method of Solubilizing Carbon Nanomaterial - [Problems] The present invention is to provide a method of solubilizing a carbon nanomaterial, in which a carbon nanomaterial can be dissolved in a hydrophilic solvent easily and uniformly without structural deterioration of the carbon nanomaterial, the dispersibility can be maintained for a prolonged period of time, the solubilizing treatment can be performed at low cost, and the treatment can be easily controlled. | 10-08-2009 |
| 20090131271 | METHOD FOR DELIVERING NUCLEIC ACID AND DEVICE FOR DELIVERING NUCLEIC ACID - In a method for delivering a nucleic acid of the invention, a nucleic acid is introduced into a cell by pressing the nucleic acid supported on a surface of a solid substrate against the cell. According to the method, the nucleic acid can be delivered into the cell simply at a low cost without placing a heavy burden on the cell at a high nucleic acid delivery efficiency. By allowing the surface of the solid substrate to support the nucleic acid in the form of a complex with a polyamine or a cationic lipid and pressing it against the cell, the introduction efficiency into the cell can be further improved. In the invention, by using a nucleic acid useful for gene therapy as the nucleic acid, a high-efficiency device for gene therapy can be obtained. | 05-21-2009 |
| 20090114374 | HEAT REMOVAL METHOD AND HEAT REMOVAL APPARATUS - A heat removal apparatus able to remove heat with a high heat flux from a large area is provided. A heat removal apparatus | 05-07-2009 |
| 20090103852 | ANALYZING ELEMENT AND ANALYZING APPARATUS USING SAME - An analyzing element ( | 04-23-2009 |
| 20090099646 | BIOFILM FORMATION INHIBITOR AND TREATMENT DEVICE THEREOF - A treatment device such as a biliary stent, capable of effectively and continuously inhibiting biofilm formation, and a biofilm formation inhibitor suitable for coating on the treatment device by killing all bacteria including | 04-16-2009 |
| 20090097021 | Substrate and Substrate Assembly for Use in Raman Spectroscopic Analysis - To provide a substrate and a substrate assembly for Raman spectroscopic analysis that are capable of analyzing even a substance of a low concentration with high sensitivity. | 04-16-2009 |
| 20090091251 | ORGANIC EL DEVICE - An organic EL device including a substrate, a positive electrode layer, a first organic layer containing a first organic light-emitting material, a negative electrode layer made of metal, and a second organic layer containing a second organic light-emitting material capable of emitting light by absorbing at least a part of light emitted from the first organic light-emitting material, in this order is provided. The negative electrode layer preferably includes a layer made of Ag. | 04-09-2009 |
| 20090090933 | METHOD OF PRODUCING STRAINED Si-SOI SUBSTRATE AND STRAINED Si-SOI SUBSTRATE PRODUCED BY THE SAME - A strained Si-SOI substrate, and a method for producing the same are provided, wherein the method includes the steps of growing a SiGe mixed crystal layer | 04-09-2009 |
| 20080291453 | Surface Plasmon Resonance Phenomenon Measuring Equipment - The present invention discloses surface plasmon resonance phenomenon measuring equipment comprising:
| 11-27-2008 |
| 20080280071 | POLYMER/LIQUID CRYSTAL COMPOSITE AND LIQUID CRYSTAL ELEMENT - The invention is generally related to a polymer/liquid crystal composite, which includes a liquid crystal material which exhibits an optically isotropic liquid crystal phase in the temperature range of approximately 5° C. or more in the elevated temperature process but does not exhibit a nematic phase; and a polymer, and which is used for an element driven in a state of the optically isotropic liquid crystal phase. | 11-13-2008 |
| 20080262080 | Allergy Suppressive Agent - The present invention provides a novel agent/composition using a bioregulatory function of a food ingredient. | 10-23-2008 |
